Tardive dyskinesia: Analysis of outpatients with schizophrenia from Africa and the Middle East, Asia, Central and Eastern Europe, and Latin America☆

Received 27 April 2004; received in revised form 6 July 2005; accepted 6 July 2005.

Abstract

The point prevalence of Tardive Dyskinesia (TD) in schizophrenia outpatients (n=6981) participating in a study of health outcomes was 8.9%. Duration of diagnosis, age, and prior use of typical antipsychotics were diagnostic indicators of TD in this population, with male sex further increasing risk. This study provides new data in a non-Western population with a unique regional geography comparison.

Keywords: Schizophrenia, Tardive dyskinesia, Prevalence, Risk factor, Antipsychotic, Africa, Asia, Mid-Eastern

a Department of General Psychiatry, Medical University of Vienna, Wahringer Gurtel 18-20, A-1090 Vienna, Austria

b Clinical Outcomes and Research Institute, Eli Lilly Australia Pty Limited, Australia

c Eli Lilly Regional Operations, Vienna, Austria

d Department of Psychiatry and Psychotherapy, Semmelweis University, Budapest, Hungary

e Eli Lilly Ges.m.b.H (Austria)

Corresponding author. Tel.: +43 1 40400 3568; fax: +43 1 40400 3099.

☆ Part of these data have been presented in poster format at the 16th Congress of the European College of Neuropsychopharmacology (ECNP) and the 42nd Annual Meeting of the American College of Neuropsychopharmacology (ACNP).

PII: S0920-9964(05)00294-X

doi:10.1016/j.schres.2005.07.032

3 of 28